Learn About Endocardial Fibroelastosis

What is the definition of Endocardial Fibroelastosis?
A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.
Save information for later
Sign Up
What are the alternative names for Endocardial Fibroelastosis?
  • Endocardial fibroelastosis
  • Endomyocardial fibroelastosis
Who are the top Endocardial Fibroelastosis Local Doctors?
CS
Claudia Stollberger
Claudia Stollberger
Elite
Highly rated in
53
conditions

Krankenanstalt Rudolfstiftung

Vienna, AT 

Claudia Stollberger is in Vienna, Austria. Stollberger is rated as an Elite expert by MediFind in the treatment of Endocardial Fibroelastosis. She is also highly rated in 53 other conditions, according to our data. Her top areas of expertise are Cramp-Fasciculation Syndrome, Cardiomyopathy, Endocardial Fibroelastosis, and Restrictive Cardiomyopathy.

View Profile
SM
Sinda Mahjoub-Zarrouk
Elite
Highly rated in
19
conditions

University Of Tunis El Manar And Genomics Platform

Tunis, TN 

Sinda Mahjoub-Zarrouk is in Tunis, Tunisia. Mahjoub-Zarrouk is rated as an Elite expert by MediFind in the treatment of Endocardial Fibroelastosis. She is also highly rated in 19 other conditions, according to our data. Her top areas of expertise are Endocardial Fibroelastosis, MELAS Syndrome, Leigh Syndrome, and Kearns-Sayre Syndrome.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
KH
Keiichi Hirono
Elite
Highly rated in
9
conditions

University Of Toyama

Department Of Pharmacy Practice And Sciences, School Of Pharmacy And Pharmaceutical Sciences 
Toyama, JP 

Keiichi Hirono is in Toyama, Japan. Hirono is rated as an Elite expert by MediFind in the treatment of Endocardial Fibroelastosis. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Endocardial Fibroelastosis, Kawasaki Disease, Cardiomyopathy, and Congenital Heart Disease CHD.

View Profile
View All Doctors
What are the latest Endocardial Fibroelastosis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Endocardial Fibroelastosis?
Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy.
Condition: Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy
Journal: Journal of cardiovascular pharmacology and therapeutics
Treatment Used: Anti-Coagulation Therapy
Number of Patients: 0
Published: June 19, 2018
View publication
Summary: Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy.
Tired of the same old research?
Check Latest Advances
View All Latest Advances